People
Appointments of Rolf Soderstrom and Dr Jim Esinhart as Non-Executive Directors
For John Cumbers, chief executive officer of SynBioBeta, turning rural America into a biotech hotbed may be an answer to kick start the local economies and advance new products that could benefit the nation and world.
Novartis Chief Executive Officer Vas Narasimhan is excited about the company’s progress through the first half of 2019 and expects that momentum to continue with a “catalyst-rich” second half of the year.
A three-judge panel ruled against Shkreli’s appeals team, claiming that the trial judge’s directions were clear and within the law.
Acacia’s founder will continue on in an advisory role while ViiV’s departing CSO is eying multiple opportunities.
Mr Vince Ippolito, a US-based dermatology industry leader with over 30 years of pharmaceuticals experience, appointed as Executive Chairman of Botanix Pharmaceuticals
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.
Pharma and biotech companies from across the globe expand their leadership teams and boards.
Karus Therapeutics Ltd, a clinical-stage biopharmaceutical company developing precision medicines for cancer, announced the appointment of Dr Hilary McElwaine-Johnn, MD as Chief Medical Officer with immediate effect.
Great Place to Work is an organization whose goal it is to assure that all people in the U.S. have a great place to work by 2030. One category for certified companies is Biotechnology & Pharmaceuticals, which listed 36 companies. BioSpace organized these 36 companies into its BioSpace Hotbed Regions. Take a look.
PRESS RELEASES